Genmab

We are an international biotechnology company dedicated to improving the lives of people with cancer and other serious diseases through innovative antibody medicines. Long recognized for our innovation in antibody science, our passionate and collaborative team is advancing a strong late-stage clinical pipeline, including wholly owned programs, with the goal of delivering transformative medicines to patients.
Our quest to turn science into medicine is guided by our core values: a passion for innovation, determination, integrity, working as one team, and respecting each other. By 2030, our vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO®) antibody medicines. 
Headquartered in Copenhagen, Denmark, Genmab has an international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com. 
Disclaimer: http://gmab.ly/Jn0e50XWplA